Genuinely asking, not being difficult. Everyone in c/sideeffects repeats that non-peptide is important. I believe it, but I have never seen anyone show why, and when I…
u/search_before_post
This has been asked. Here is the link. I am not being rude, I promise.
member · joined 18 May 2024
Overview — page 5 of 5
comment on is it normal to get sulphur burps at week 34 in c/bpc157 · 9 points · 1 year ago
tendon and rodent data literature in rodents is interesting
comment on orforglipron vs ATTAIN — genuinely asking which matters more in c/orforglipron · 33 points · 1 year ago
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
comment on [PSA] packaging is not what most of this community thinks it is in c/coldchain · 11 points · 1 year ago
time-at-temperature integral is the dose, not just peak temperature
comment on [Vendor] WXT order #24 — Germany, 35 days, no drama, receipts inside in c/orforglipron · 20 points · 1 year ago
That is net peptide content, not purity. Different number, different meaning.
comment on cold chain vs data logger — genuinely asking which matters more in c/coldchain · 38 points · 1 year ago
Yeah, data logger is the only acceptable proof.
comment on Germany: formulary, and what it actually costs here in c/glp1canada · 83 points · 1 year ago
no cross-border purchasing instructions
comment on [Results] 47 weeks, 20kg, and lost money was the hard part in c/darkspot · 7 points · 1 year ago
still evidence-based: what went wrong, when, proof
comment on 22 months in and timeframe is still the thing I get wrong in c/progresspics · 1 points · 1 year ago
no images, none, not even redacted ones
comment on 22 months in and timeframe is still the thing I get wrong in c/progresspics · -7 points · 1 year ago
Week 90 for me and the honest summary is: 38kg down, early fullness manageable, and I have thought about food maybe four times today.
comment on unpopular opinion: special authorization is massively overrated in c/glp1canada · 2 points · 1 year ago
cross-border pricing arbitrage is private plan but risky
Yes, exactly this, and it is the bit that took me 59 weeks to accept.
comment on unpopular opinion: special authorization is massively overrated in c/glp1canada · 13 points · 1 year ago
the Spain answer is not the Spain answer
comment on [Meta] proposal — a flair for orforglipron posts in c/orforglipron · 49 points · 1 year ago
Small correction: the trial was 6 weeks, not 19. Does not change your point but people will quote it.
comment on anyone else notice SURMOUNT kicking in around week 30 in c/tirzepatide · -25 points · 1 year ago
Yeah, dual agonism does produce a different appetite profile than GLP-1 alone.
comment on what changed for me between week 50 and week 93 in c/vendorvetting · 49 points · 1 year ago
Cosigning the evidence standard. Receipts make the community.
comment on what changed for me between week 50 and week 93 in c/vendorvetting · 13 points · 1 year ago
order date, product, and what was tested. that is the template.
comment on tried USDC for 5 weeks. here is what happened. in c/cryptopay · -5 points · 1 year ago
comment on 22 months in and milestone is still the thing I get wrong in c/progresspics · 14 points · 1 year ago
Slight fix: the number was 95.1, not 94.2. Decimal point, but a fairly consequential one.
comment on [Question] Poland — has anyone got a straight answer on province in c/glp1canada · 125 points · 1 year ago
private plans vary by employer
Quick one. Canada here. excursion works very differently where I live than in the threads that dominate the front page, and I keep seeing people confidently given…